Doxorubicin-fucoidan-gold nanoparticles composite for dualchemo- photothermal treatment on eye tumors

59Citations
Citations of this article
53Readers
Mendeley users who have this article in their library.

Abstract

The current research demonstrates the feasible biomedical application of AuNPs coated with doxorubicin (Dox)-loaded fucoidan (Fu) for dual-chemotherapy and photothermal treatment (PTT) on eye tumors in vitro and in vivo. Marine-derived Fu was used as a capping agent to achieve high photostability for AuNPs, and Dox as a FDAapproved anti-cancer drug was added to induce chemotherapy. The synthesized Dox- Fu@AuNPs exhibited high cytotoxicity on the tumor cells and strong light absorption for temperature increase in vitro. After intratumoral injection of Dox-Fu@AuNPs in the rabbit eye tumors, PTT-assisted Dox-Fu@AuNPs entailed the complete removal of the eye tumors without recurrence for 14 days after the treatment. Photoacoustic image contrast from the tumor regions was enhanced due to selective light absorption by the administered Dox-Fu@AuNPs. Therefore, the proposed Dox-Fu@AuNPs can be a potential nano-theranostic material for treating and diagnosing the eye tumors.

Cite

CITATION STYLE

APA

Kim, H., Nguyen, V. P., Manivasagan, P., Jung, M. J., Kim, S. W., Oh, J., & Kang, H. W. (2017). Doxorubicin-fucoidan-gold nanoparticles composite for dualchemo- photothermal treatment on eye tumors. Oncotarget, 8(69), 113719–113733. https://doi.org/10.18632/oncotarget.23092

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free